Cargando…

Elevated Preoperative Serum CA19-9 Levels in Patients with Hepatocellular Carcinoma Is Associated with Poor Prognosis after Resection

Serum levels of the tumor marker CA19-9 have been reported to be elevated in patients with hepatocellular carcinoma (HCC), but its clinicopathologic significance is still unknown. A cohort of 304 patients undergoing surgical resection for HCC and having preoperative CA19-9 data was enrolled in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Ling, Chen, Chien-Hung, Hu, Rey-Heng, Ho, Ming-Chih, Jeng, Yung-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694498/ https://www.ncbi.nlm.nih.gov/pubmed/23843733 http://dx.doi.org/10.1155/2013/380797

Ejemplares similares

Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
por: Tsai, Ming-Chao, et al.
Publicado: (2019)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Expression of Hypoxic Marker Carbonic Anhydrase IX Predicts Poor Prognosis in Resectable Hepatocellular Carcinoma
por: Huang, Wei-Ju, et al.
Publicado: (2015)

Increased Trimethylation of histone H3K36 associates with biliary differentiation and predicts poor prognosis in resectable hepatocellular carcinoma
por: Lien, Huang-Chun, et al.
Publicado: (2018)

Preoperative inflammatory markers of NLR and PLR as indicators of poor prognosis in resectable HCC
por: Wang, Dong, et al.
Publicado: (2019)

Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation
por: Fu, Shun-Jun, et al.
Publicado: (2016)

Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
por: Jiang, Chang, et al.
Publicado: (2016)

Overexpression of CTHRC1 in Hepatocellular Carcinoma Promotes Tumor Invasion and Predicts Poor Prognosis
por: Chen, Yu-Ling, et al.
Publicado: (2013)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study
por: Dong, Qian, et al.
Publicado: (2014)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
por: He, Chaobin, et al.
Publicado: (2018)

Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis
por: Sun, Xiao-Dong, et al.
Publicado: (2016)

Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2022)

Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma
por: Song, Qian, et al.
Publicado: (2019)

Coexistence of Perineural Invasion and Lymph Node Metastases Is a Poor Prognostic Factor in Patients with Locally Advanced Rectal Cancer after Preoperative Chemoradiotherapy Followed by Radical Resection and Adjuvant Chemotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2014)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma
por: Sun, Yifan, et al.
Publicado: (2017)

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014)

Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study
por: Huang, Jun-Hua, et al.
Publicado: (2022)

Preoperative Serum CA125 Levels Predict the Prognosis in Hyperbilirubinemia Patients With Resectable Pancreatic Ductal Adenocarcinoma
por: Chen, Tao, et al.
Publicado: (2015)

Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma
por: Chen, Yao, et al.
Publicado: (2021)

Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma
por: Hu, Hai-Jie, et al.
Publicado: (2016)

Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
por: Fang, Tianyi, et al.
Publicado: (2019)

Preoperative elevated neutrophil-to-lymphocyte ratio (NLR) and derived NLR are associated with poor prognosis in patients with breast cancer: A meta-analysis
por: Duan, Junwu, et al.
Publicado: (2018)

The Association of Preoperative PET-CT and Survival in Patients with Resectable Cervical Cancer
por: Su, Chih-Hsiung, et al.
Publicado: (2022)

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
por: Szkandera, J, et al.
Publicado: (2013)

Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma
por: Chen, Rui-Qiu, et al.
Publicado: (2023)

Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection
por: Perng, Daw-Shyong, et al.
Publicado: (2021)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

High S100A9(+) cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection
por: Liao, Jing, et al.
Publicado: (2021)

Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
por: Huang, Yao, et al.
Publicado: (2020)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor
por: Chang, Wei-Long, et al.
Publicado: (2020)

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
por: Yang, Yi-Chieh, et al.
Publicado: (2021)

Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
por: Liu, Qingqing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_i70b9st86tlngsb72vt9km4p6b